Strategic National Account Leader – Renal Dialysis

Akebia Therapeutics; San Francisco (CA); Hybrid; USD 179,000 - 221,000; Full time

Benefits offered by this job

Health care

Vision insurance

Dental insurance

Retirement plan

Paid time off

Job summary

Akebia Therapeutics is seeking a National Account Manager to lead strategic partnerships with Dialysis Organizations and Nephrology Large Group Practices. You will drive access, adoption of Vafseo, and align with regional executives across Northern California.

Key duties include national/regional planning, cross-functional collaboration, and presenting medical and economic data to health-system leaders. Travel up to 50% is expected, with hybrid in-office options.

Qualifications

• BA/BS required; advanced degree preferred.
• Minimum 5 years’ experience in Renal or similar therapeutic space.
• Proven track record of effective account management skills.
• Experience in biopharmaceutical sales and national accounts is a plus.

Responsibilities

• Develop and execute national and regional account strategies.
• Drive Vafseo access across dialysis organizations.
• Lead quarterly business reviews with executives within accounts.
• Collaborate with LDO/MDOs, LGPs, and IDNs on strategic initiatives.
• Support Medical Director and physician programs.
• Communicate clinical, economic data to customers effectively.
• Travel up to 50% within the U.S.

Skills

Account management

Communication

Negotiation

Presentation skills

Planning & organizing

Sales experience

Renal/biopharma domain

Education

BA/BS

Advanced degree preferred

Job description

Akebia Therapeutics is seeking a National Account Manager to lead strategic partnerships with Dialysis Organizations and Nephrology Large Group Practices. You will drive access, adoption of Vafseo, and align with regional executives across Northern California.

Key duties include national/regional planning, cross-functional collaboration, and presenting medical and economic data to health-system leaders. Travel up to 50% is expected, with hybrid in-office options.